Freshtrop Fruits Limited operates in the business of exporting grapes and pomegranates from India to supermarkets across Europe. The company has categorized its operations into two main segments for reporting purposes:
As a prominent supplier, Freshtrop consistently delivers high-quality grapes and pomegranates to supermarkets in Europe and Russia. Additionally, the company has established a food processing facility in Nasik, India, focusing on producing fruit pulp including mango and guava pulp, as well as tomato paste, among other products.
Corporate Action | |
---|---|
Security Name | Freshtrop Fruits Ltd |
Buyback Date | April 8, 2024 - April 16, 2024 |
Issue Type | Tender Offer |
Issue Size (Shares) | 1,925,000 (19.45 % of Total number of equity Shares) |
Issue Size (Amount) | ₹33.69 Crores |
Buyback Price | ₹175 per share |
Record Date | April 2, 2024 |
CMP | ₹161 |
Retail Category Participation Criteria | * Retail shareholders holding less than Rs 2 Lac Value shares as on "Record Date"* |
The proposal suggests buying back a maximum of 19,25,000 (Nineteen Lakhs Twenty-Five Thousand) equity shares of the Company. This represents 19.45% of the total equity shares in the paid-up share capital. The buyback price is fixed at Rs. 175/- (Rupees One Hundred Seventy-Five Only) per equity share, to be paid in cash. The total amount for this buyback is capped at Rs. 33,68,75,000/- (Rupees Thirty-Three Crore Sixty-Eight Lakhs Seventy-Five Thousand only).
Disclaimer: The Information compiled by CEBPL on a best efforts basis from information CEBPL received from third party vendors, believed to be reliable. The information may contain errors or omissions; and is subject to change without prior or additional notice. CEBPL provides corporate action information that may be of interest or relevance to CEBPL clients. This does not constitute a recommendation or advice by CEBPL, and CEBPL Clients may not rely upon it. CEBPL does not warrant that the information provided is accurate, timely, or complete. CEBPL Clients are urged to verify the information prior to using it in their investing and trading decisions, including, but not limited to, referral to independent financial news resources, company announcements, and regulatory filings or disclosures. "Investment in securities market are subject to market risks, read all the related documents carefully before investing". Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of retums to investors. Name of Compliance Officer- Prashant Salian Email Id-Prashant.salian@choiceindia.com Contact no. 022-67079999-Ext-2310. Name of Grievance Officer-Deepika Singhvi-Email Id-ig@choiceindia.com, Contact no. 022-67079999-Ext-834. www.choiceindia.com
Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.